Search Results 171-180 of 18375 for Parkinson's disease
The Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D. at Mayo Clinic collaborates with numerous researchers and labs.
The synucleinopathies, as these disorders are known, include Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Toxic clumps of ...
... Parkinson's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Men who have had head trauma, used pesticides and don't drink coffee are more likely to be associated with Parkinson's disease.
... Parkinson's disease. Very rarely, eye twitching may be a sign of certain brain and nervous system disorders. In these cases, it's almost always accompanied ...
For Parkinson's disease: Adults—At first, 2 milligrams (mg) once a day for 1 to 2 weeks. Your doctor may adjust your dose as needed and tolerated. However ...
Trihexyphenidyl is used alone or together with other medicines (e.g., levodopa) to treat Parkinson's disease. By improving muscle control and reducing ...
... Parkinson's disease, essential tremor, and dystonia, among others. "Deep brain stimulation is a procedure where electrodes are placed in certain target ...
Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes · Overview · Participation eligibility · Participating Mayo ...
Parkinsonism is the label for a broad spectrum of movement disorders that includes Parkinson's disease. Common symptoms are tremors and bradykinesia, the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.